Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × IFL protocol × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Ras-mutated Metastatic Colorectal Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 13 Rituximab 12 fludarabine 10 obinutuzumab 9 Prednisone 7 ibrutinib 6 Lenalidomide 6 tocilizumab 5 fludarabine phosphate 5 Biopsy 5 venetoclax 4 pirtobrutinib 4 glofitamab 4 Specimen Handling 4 Doxorubicin 4 polatuzumab vedotin 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 tucatinib 2 temsirolimus 2 pertuzumab 2 palbociclib 2 olaparib 2 cobimetinib 2 acalabrutinib 2 Whole-Body Irradiation 2 Vemurafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡